Among patients with lymphoma undergoing a certain type of chemotherapy, receiving the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV reactivation, compared with the antiviral drug lamivudine, according to a study.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/cpWpwkgrnZA/141216161445.htm
Effectiveness of drugs to prevent hepatitis among patients receiving chemotherapy
16 diciembre 2014
Volver